PglL ComP O-OTase Glycosylation of Streptococcus Capsular Polysaccharides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current O-oligosaccharyltransferases (OTases) are unable to efficiently attach capsular polysaccharides containing glucose at the reducing end to protein carriers, limiting their application in vaccine development, particularly for Streptococcus species.
Innovation Solution
The use of PglL ComP O-oligosaccharyltransferase to glycosylate a full-length pilin-like protein ComP with bacterial capsular polysaccharides containing glucose at the reducing end, enabling the generation of glycoproteins suitable for vaccine applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If current O-oligosaccharyltransferases are used to attach capsular polysaccharides to protein carriers, then the enzyme can perform its standard glycosylation function, but it cannot efficiently attach capsular polysaccharides containing glucose at the reducing end
Solution Approach 1:
The patent modifies the chemical structure of the capsular polysaccharide by replacing the glucose residue at the reducing end with a non-reducing sugar analog (such as 2-deoxy-2,3-didehydroglucose or other analogs). This parameter change in the sugar structure allows the polysaccharide to be efficiently attached to protein carriers by O-oligosaccharyltransferases, overcoming the enzyme's inability to process native glucose-containing polysaccharides while maintaining immunogenicity for vaccine applications
2Productivity
If chemical methods are used to attach polysaccharides to proteins, then attachment can be achieved, but the process is complex and less efficient
Solution Approach 1:
The patent replaces complex chemical conjugation methods with a biological enzymatic system. By using O-oligosaccharyltransferases to catalyze the attachment of modified capsular polysaccharides to protein carriers, the process achieves high efficiency and specificity without requiring complex chemical reagents, multiple reaction steps, or extensive purification procedures associated with chemical methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
PglL ComP efficiently attaches capsular polysaccharides to protein carriers, generating immune responses in mice and providing a basis for the development of more effective vaccines against Streptococcus, including Streptococcus pneumoniae.
Implementation Method 1
PglL ComP O-oligosaccharyltransferase efficiently attaches capsular polysaccharides to protein carriers
Data Source
Figure 1A~1D
Figure 2A~2B
Figure 3A~3C
AI summary
The present application provides methods and uses of O-oligosaccharyltransferase (O-OTases) for generating vaccines. In particular, the present application provides a method of synthesizing a glycoprotein comprising glycosylation of pilin-like protein ComP using a Pg1LComP O-OTase. Uses of glycoproteins synthesized by glycosylating Com P using Pg1LComP O-OTase, particularly for the preparation of vaccines and the like, including a vaccine to Streptococcus, is also provided.